Latest in Liver Disease & Fatty Liver

manilatimes.net
272 words

Madrigal to Present Multiple Abstracts at AASLD's The Liver Meeting 2026, Including New Real-World Evidence Reinforcing Rezdiffra as a Foundational Therapy for MASH

Madrigal Data Presentations at AASLD’s The Liver Meeting 2026 Once patients progress to MASH with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis), the risk of adverse liver outcomes increases dramatically: these patients have a 10 to 17 times higher risk…

Liver Disease & Fatty Liver

Fatty liver disease (MASLD and MASH), cirrhosis and liver failure: diagnosis, new liver drugs and research on protecting the liver.

  • 23 Tracked terms
  • Last 30 days Feed window

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.